HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Soligenix
Soligenix
City of Hope Medical Center
Northwestern University
National Cancer Institute (NCI)
University of Nebraska
Eastern Cooperative Oncology Group
Soligenix
OncoSec Medical Incorporated
Mayo Clinic
miRagen Therapeutics, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
Novartis
Northwestern University
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
National Cancer Institute (NCI)
University of Chicago
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Stanford University
Alliance for Clinical Trials in Oncology
Mayo Clinic
Vanderbilt University
Northside Hospital, Inc.